Super Prostate Product - More Beta-sitosterol, all-natural Best Prostate(TM) Formula for Enlarged Prostate and BPH - Increases Urine Flow, Reduces Waking and Improves Quality of Life
NORTH HOLLYWOOD, Calif., Feb. 28 /PRNewswire/ -- Men, do you have
difficulty urinating, have decreased flow, wake often in the night with a
sense of urgency, feel the need to urinate but can't? If you or someone you
know has been diagnosed or suffers from the symptoms of
BPH or an enlarged
pro...
Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH
New York, August 19, 2008 Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of erectile dysfunction drug tadalafil (Cialis) to relieve associated lower urinary tract symptoms (LUTS), according to a new study published in the October 2008 issue of The Journal of...
Emerson Ecologics Names Michelle Hebert New England Regional Sales Representative
...joining Emerson, Michelle worked for Merck in the health fields of osteoporosis, asthma, allergies, cardiovascular medicine, GERD (reflux disease) and
bph (prostate health). Most recently she was Senior Executive Specialty Sales Representative and covered virtually all of New England. Michelle received ...
Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year
...p an enlarged prostate, also known as Benign Prostatic Hypertrophy, or BPH. The statistics are not precise, but about half of men of any age who have
bph will have symptoms that require attention and treatment that may involve taking one of the drugs evaluated in the report.
"This means that mill...
Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region
...C in Kabul, Afghanistan to AKUH in Karachi, Pakistan, enabling access to a broad array of radiology expertise provided by AKUH. The second phase links
bph to the FMIC, which is being developed as an Afghan center of medical excellence. To date, more than 340 patients have benefitted from Telemedicine and...
Enlarged Prostate and Erectile Dysfunction Are Subjects of Free Men's Health Seminar
... above the age of 60 in the United States. Benign Prostate Hyperplasia, or BPH, is a natural, non-cancerous enlargement of the prostate. Symptoms of
bph include frequent urination, weak flow, and interrupted sleep--factors that can significantly impact a man's quality of life.
Many men are commonl...
AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results
...alties on future net sales of cetrorelix for
bph in the U.S.;
- Sanofi-aventis responsible for ...tained certain rights to co-promote cetrorelix for
bph in
the U.S.
Juergen Engel, Ph.D., AEte...and marketing of our lead compound, cetrorelix, in
bph for the United States market. The agreement is an ...
Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients
...uthor of one of the AUA abstracts. "For the older
bph patient who experiences retrograde ejaculation, it...s that treatment with RAPAFLO (TM) offers."
bph is the number one reason patients visit urologists... results in improved urine flow and a reduction in
bph symptoms. The binding affinity for the alpha (1B)...
Data Show Dutasteride Reduces Prostate Cancer Diagnosis in Men With Increased Risk
...ter risk for the men who did develop prostate cancer to have aggressive tumors. This outcome was closely watched because an earlier trial of a similar
bph drug - finasteride (Proscar) - produced controversial results with regard to the risk of more aggressive tumors in those men who developed prostate ca...
Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
... measures both UEBW (ultrasound-estimated bladder weight) and bladder volume quickly and noninvasively to help diagnose bladder dysfunction, including
bph (benign prostatic hypertrophy) and BOO (bladder outlet obstruction). This new addition to the BladderScan(R) BVI 9000 series made its official debut ...
BPH in Medical Technology
AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2
Data for Ozarelix, in BPH at Annual AUA Meeting
Ozarelix improved LUTS symptoms and urine flow over 28-week period
QUEBEC CITY, May 23, 2007 /PRNewswire-FirstCall/ - AEterna
Zentaris Inc. , a global biopharmaceutical company focused on
endocrine therapy and oncology, today announced that its partner
Spectrum Pharmaceuticals presented an abstrac...
Clinical Data From Nymox BPH Drug To Be Presented at American
Urological Association Meeting
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jul 3, 2007 - Nymox
Pharmaceutical Corporation (NASDAQ: NYMX) today announced that
further clinical results from the Company's studies of NX-1207 for
benign prostatic hyperplasia (BPH) will be presented at the New
England Section of the American Urological ...
Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207
for BPH
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Apr 18, 2007 - Nymox
Pharmaceutical Corporation (NASDAQ: NYMX) announced today
completion of a new 42 month follow-up study of NX-1207 for benign
prostatic hyperplasia (BPH). The study evaluated symptomatic
progress of U.S. patients involved in the Company'...
Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
...atic hypertrophy (BPH) and affects at least 70% of
bph patients.
There is currently no adequate treatment...n prostatic hypertrophy (BPH) with at least 70% of
bph patients
complaining of nocturia. Whilst some symptoms of
bph are successfully
addressed by the standard...
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
...the signs and symptoms associated with BPH."
bph is the number one reason patients visit urologists... results in improved urine flow and a reduction in
bph symptoms. The binding affinity for the alpha (1B) ...tical Co., Ltd. in Japan, where RAPAFLO(TM) is the
bph market leader, and licensed to Watson for the U.S....
Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
... (BPH). D-3263 demonstrated the ability to reduce
bph alone and in combination with finasteride, a curre.... to 12:30 p.m. CDT.
In a preclinical study,
bph was induced in rats through subcutaneous injection...examined histologically.
Rats with TP-induced
bph who were treated with D-3263, finasteride or a com...
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
...he initial dose. In addition, noticeable relief of
bph symptoms was realized in just three to four days, ...id efficacy and safety of RAPAFLO(TM) will provide
bph patients and their physicians an important treatme...esulting in improved urine flow and a reduction in
bph symptoms. The binding affinity for the alpha 1B r...
Vantia Therapeutics' Pipeline Continues to Mature
...velopment after the Phase IIb results. Nocturia in
bph is
believed to represent a potential market in exc...n prostatic hypertrophy (BPH) with at least 70% of
bph patients
complaining of nocturia. Whilst some symptoms of
bph are successfully
addressed by the standard...
Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
...ical study in glioma in the second half
of 2008.
bph is a common result of aging and is estimated to occur in more than
14 million American men.
bph rarely causes symptoms before age 40, but more
tha... Early stage treatment is critical,
because severe
bph can cause serious problems over time, such as urin...
Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
...21, 2008, at 2:50 PM ET.
In a preclinical study,
bph was induced through subcutaneous injection
of test...as a drug
candidate for the potential treatment of
bph -- a disease affecting a
substantial number of men...ndrogen metabolism, which is a known stimulant for
bph and prostate
cancer. These effects were seen in a ...
BPH in Medical Products
Total PSA IRMA Test
Description:...(i.e. free PSA, PSA-ACT complex and total PSA) may be useful to distinguish
bph from untreated prostate cancer. The ratio of free PSA to PSA-ACT is lower i... percentage) has been proposed as a means to improve discrimination between
bph and untreated prostate cancer in patients [1,3,5,6].
It has been foun...
Company:Diagnostic Systems Laboratories, Inc.
TherMatrx® Dose Optimized Thermotherapy™
Description:...ign prostate hyperplasia (BPH). TherMatrx is the most widely used in-office
bph thermotherapy treatment in the United States. Unlike surgical solutions for...timal dose of heat needed for each patient to provide significant relief of
bph symptoms with minimal side effects and excellent in-office tolerance. This ...
Company:AMS
Lumenis VersaPulse PowerSuite
Description:... HoLAP is a safe, effective and relatively bloodless procedure for immediate resolution of
bph symptoms. It is easy to learn and can be performed in less than an hour in an outpatient setting with few if any patient complications. Surgeons can q...
Company:Lumenis, Inc.
AquaTherm Water-Induced Thermotherapy (WIT) System
Description:... One of the most innovative and elegantly simple alternatives for
bph treatment, Water-Induced Thermotherapy (WIT) provides an ideal solution for physicians seeking to treat patients in the office. No other option provid...
Company:GYRUS ACMI
Total PSA ELISA Test
Description:...(i.e. free PSA, PSA-ACT complex and total PSA) may be useful to distinguish
bph from untreated prostate cancer. The ratio of free PSA to PSA-ACT is lower i... percentage) has been proposed as a means to improve discrimination between
bph and untreated prostate cancer in patients [1,3,5,6].
It has been foun...
Company:Diagnostic Systems Laboratories, Inc.
The Prostatron® System
Features:... Prostatron treatment provides lasting relief for millions of
bph patients: More cost effective than a lifetime regimen of drug therapy Single office treatment without anesthesia Better than medication in improving I...
Company:Urologix, Inc.
BPH in Medical Dictionary
Bph
Benign prostatic hyperplasia (
BPH ) also known as nodular hyperplasia, benign prostatic hypertrophy or benign enlargement of the prostate (BEP) refers to the increase in size of the prostate in middle-aged and elderly men. To... Information about the prostate gland, symptoms, dia...
Prostate Disease
...ect men differently depending on whether they have
bph or enlarged prostate , prostate cancer, or pros...and in men. ... What is prostate disease ? ...
bph can raise PSA ( prostate -specific antigen) levels...gn ... What is prostate enlargement, or BPH? Is
bph a sign of cancer? Is...
Prostate
...nign prostatic hyperplasia. ... What is prostate enlargement, or BPH? Is
bph a sign of cancer? Is
bph a ... Prostate cancer is diagnosed in an estimated 80% of men who r...
Hypertrophy
...H, herbal remedies for BPH, causes and symptoms of
bph ... Benign prostatic hypertrophy or
bph - Definition.
bph Causes and Symptoms ... What is hypertrophy ?...
Benign Prostatic Hyperplasia
...or benign prostate enlargement described here.
bph involves hormones and ... Benign prostatic ...atic Hyperplasia Pathology. As discussed above,
bph ... ... Bad Are Your Urinary Symptoms From Be...t benign prostatic hyperplasia (BPH) ...
bph OVERVIEW Benign prostatic hyperplasia is a c...
Benign
...mation about benign in the free online English dictionary and encyclopedia. benign tumors, ... benign ... 2 not fatal a benign tumour. ...
bph OVERVIEW Benign prostatic hyperplasia is a condition that occurs when the ... Clinical manifestations and diagnosis of benign prostatic hyper...
BPH in Biological News
Research required urgently to control planthopper pests
...ssary insecticide use, and breeding BPH-resistant rice varietieshelped keep
bph under control for the next 20 years. However, in the last 5 years, planthop...lso allows the pests to become resistant to pesticides."
Since the first
bph conference, genetics, ecology, and pest management have advanced considerab...
Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds
...nd Drug Administration for this use. Patients with
bph must strain to pass urine and feel the urge to urinate frequently.
bph can lead to the inability to urinate and urinary t...patients who take the finasteride drug Proscar for
bph get a five times higher dosage, 5 mg per day. "The...
Exposure to dioxins influences male reproductive system, study of Vietnam veterans concludes
... (BPH), better known as enlarged-prostate disease.
bph is a disease in humans that is caused by an enlarg... pass urine and they also must urinate frequently.
bph can lead to complications such as an inability to ...n the human body. The study indirectly proves that
bph is an endocrine disorder."
Regarding the decr...
Human prostate grown from embryonic stem cells
...ly significant - up to 90 percent of men will have
bph by the time they reach 80 years of age.
bph is not usually life-threatening, but has a dramati...l have a significant impact on prostate cancer and
bph research.
"If we can understand how to make nor...
BPH in Biological Technology
AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
QUEBEC CITY, May 13 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.
(NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on
endocrine therapy and oncology, today announced that the article titled
"Placebo-controlled dose-ranging Phase 2 study of subcutaneously
administered LHR...
AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
QUEBEC CITY, April 30 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.
(NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on
endocrine therapy and oncology, today announced that Prof. Frans M.J.
Debruyne, M.D., Ph.D., Chairman and CEO of Andros Men's Health Institutes
in The ...
AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
...ind placebo controlled efficacy study (study 033).
bph is a benign enlargement of the prostate, affecting... stage of the Phase 3 development of cetrorelix in
bph and look forward to the data emerging in the next ...
About the Phase 3 Program with Cetrorelix in
bph
Cetrorelix pamoate is currently in three Phas...
AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia
...pment, registration and marketing of cetrorelix in
bph for the U.S. market.
As a result of this collabo...
About the Phase 3 Program with Cetrorelix in
bph
Cetrorelix pamoate is currently in three Phas...nvolving more than 1,600 patients with symptomatic
bph in Canada, the United States and Europe.
The fir...
Ausio Pharmaceuticals to Present at Bio(R) 2009
...old higher than the expected therapeutic range.
Phase 2 clinical trials to assess the efficacy of AUS-131 for relief of menopausal symptoms and
bph are on schedule to begin September 2009. The expected completion date for the Phase 2 clinical trials is Q2 2010.
About AUS-131
AUS-131 is ...
Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
...results
expected mid 2009.
Nocturia is commonly associated with benign prostatic hypertrophy (BPH)
where it is estimated to affect up to 70% of
bph patients. With estimates
putting the number of BPH/nocturia sufferers at 55 million in the seven
largest markets world wide, and only 10% of these bel...
AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results
...t efficacy study of the
Phase 3 program in
bph with cetrorelix.
- May
- First patient...the safety trial of the Phase 3
program in
bph with cetrorelix.
- Appointment of Matthias S...egistration and
marketing of cetrorelix in
bph for the United States market. The
agreemen...
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
...it royalties on future net sales of cetrorelix for
bph in the United States. Sanofi-aventis will be respo...tained certain rights to co-promote cetrorelix for
bph in the U.S. market. Finally, sanofi-aventis may pe...
About the Phase 3 Program with Cetrorelix in
bph
Cetrorelix pamoate is currently in three Phas...
Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
...the PAH indication in the U.S.,
Japan, Europe, Canada and Mexico. The company also anticipates initiating
enrollment in additional Phase III trials in
bph in the first quarter of 2009.
In November, 2008, the company licensed the U.S. rights for the PAH indication
to United Therapeutics.
Worldwide...
AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
...f another agreement with Handok for the commercialization of ozarelix in
bph for the Korean market; and - Recovery of worldwide rights from Ardana plc ...ent goals as
scheduled and remain on track. First results for cetrorelix in
bph are
still expected in the third quarter of 2009, while those for AEZS-108
s...